´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 8¿ù ¿¬¼ö°Á : 2018-08-21±³À°ÀÏÀÚ : 2018-08-21
±³À°Àå¼Ò : ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ
±³À°ÁÖÁ¦ :
´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 8¿ù ¿¬¼ö°Á ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÀü¤ýÃæûÁöȸ
´ã´çÀÚ : ±èÁÖ¿Á
¿¬¶ôó : 02-0000-0000
À̸ÞÀÏ:
jokim@cnu.ac.kr ±³À°Á¾·ù : ³»°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 45¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
Ãæû³²µµ±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 18:30~19:20 Treatment Guidelines for Multi-Drug-Resistant Tuberculosis(MDR-TB) ÀüµÎ¼ö(¾ç»êºÎ»ê´ëÇб³º´¿ø)
Åä·Ð 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 19:20~19:30 ÅäÀÇ ()
±³À°½Ã°£ 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 19:30~20:20 Current Treatment of MDR-TB in Korea with Preliminary Case Review Committee ³ªÁÖ¿Á(¼øõÇâ õ¾Èº´¿ø)
Åä·Ð 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 20:20~20:30 ÅäÀÇ ()
±³À°½Ã°£ 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 20:30~21:20 Treatment Experiences of MDR-TB Patients ÀÌÀ±°æ(Ãæ³²´ëÇб³º´¿ø)
±³À°½Ã°£ 08¿ù 21ÀÏ ¼øõÇâ´ëÇб³ õ¾Èº´¿ø ¼Û¿øȦ 21:20~21:30 Panel discussion ()